0000899243-21-010346.txt : 20210308
0000899243-21-010346.hdr.sgml : 20210308
20210308161519
ACCESSION NUMBER: 0000899243-21-010346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200508
FILED AS OF DATE: 20210308
DATE AS OF CHANGE: 20210308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIDRANSKY DAVID
CENTRAL INDEX KEY: 0001277161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39279
FILM NUMBER: 21722130
MAIL ADDRESS:
STREET 1: JOHNS HOPKINS UNIVERSITY
STREET 2: 720 RUTLAND AVENUE
CITY: BALTIMORE
STATE: MD
ZIP: 21205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001797336
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823578375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: (857) 444-0553
MAIL ADDRESS:
STREET 1: 1313 N. MARKET STREET
STREET 2: SUITE 5100
CITY: WILMINGTON
STATE: DE
ZIP: 19801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-08
0
0001797336
Ayala Pharmaceuticals, Inc.
AYLA
0001277161
SIDRANSKY DAVID
12/15 MOSKOVITZ ST.
REHOVOT
L3
7647412
ISRAEL
1
0
0
0
Common Stock
2020-05-08
4
P
0
200
15.27
A
200
I
Held by Reporting Person's son
Common Stock
2020-05-12
4
P
0
25
15.02
A
225
I
Held by Reporting Person's son
Common Stock
2020-07-07
4
P
0
1
9.60
A
226
I
Held by Reporting Person's son
Common Stock
2020-07-17
4
P
0
4
11.86
A
230
I
Held by Reporting Person's son
Common Stock
2020-08-14
4
P
0
5
11.07
A
235
I
Held by Reporting Person's son
Common Stock
2020-09-11
4
P
0
10
10.07
A
245
I
Held by Reporting Person's son
Common Stock
2020-09-14
4
P
0
1
10.70
A
246
I
Held by Reporting Person's son
Common Stock
2020-12-23
4
P
0
4
11.56
A
250
I
Held by Reporting Person's son
/s/ Roni Mamluk, Ph.D., Attorney-in-Fact for David Sidransky
2021-03-08